Cargando…
m6A‐related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma
BACKGROUND: N6‐methyladenosine (m6A) has been identified as the most common, abundant, and conserved internal transcriptional modification. Long noncoding RNAs (lncRNAs) are noncoding RNAs consisting of more than 200 nucleotides, and the expression of various lncRNAs may affect cancer prognosis. The...
Autores principales: | Zhou, Xinying, Zhang, Hu, Duan, Yingchun, Zhu, Jianlong, Dai, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833960/ https://www.ncbi.nlm.nih.gov/pubmed/36525280 http://dx.doi.org/10.1002/jcla.24813 |
Ejemplares similares
-
N6-Methyladenosine-Related Long Noncoding RNAs as Potential Prognosis Biomarkers for Endometrial Cancer
por: Shi, Rui, et al.
Publicado: (2021) -
Long noncoding RNAs as tumorigenic factors and therapeutic targets for renal cell carcinoma
por: Shen, Haiyan, et al.
Publicado: (2021) -
Machine Learning Supports Long Noncoding RNAs as Expression Markers for Endometrial Carcinoma
por: Mello, Ana Carolina, et al.
Publicado: (2020) -
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
por: Yang, Zuozhang, et al.
Publicado: (2016) -
Potentials of Long Noncoding RNAs (LncRNAs) in Sarcoma: From Biomarkers to Therapeutic Targets
por: Min, Li, et al.
Publicado: (2017)